Ultimately, the GPX4 protein is a novel target for breast cancer therapy, particularly TNBC, and it offers a novel strategy for TNBC treatment by reducing GPX4 expression and inducing ferroptosis. This evidence concerns the gene GPX4 and breast carcinoma.